Home » Funding

Funding

Grants

National Institutes of Health

US-NIH-NIAMS-Logo_s

We currently hold one grant from the National Institutes of Arthritis and Musculoskeletal and Skin Diseases (NIAMS, NIH) for our studies of dysferlin and dysferlinopathies, and will soon have a grant pending for our studies of sAnk1 and its interactions with SERCA and obscurin.

 

NINDS-logo_sWe hold a grant from the National Institutes of Neurological Diseases and Stroke (NINDS) for our xenografting studies.

 

Muscular Dystrophy Association


MDA-logo_s
We have received almost continuous funding from the Muscular Dystrophy Association for a range of our studies on muscle and muscular dystrophies.

 

Jain Foundation

Jain-logo_sWe have received a research grant annually from the Jain Foundation to develop new approaches to studying the role of dysferlin in skeletal muscle, to understand the etiology of Limb Girdle Muscular Dystrophy Type 2B and Miyoshi Myopathy, and to test small molecules in mice that may be useful in treating these diseases in man.

 

FSH Society

We have received small grants and postdoctoral fellowships from the FSH Society (Lexington, MA) for studies of  Facioscapulohumeral Muscular Dystrophy. We currently hold a grant jointly with the Jones Laboratory (UMass Med School, Worcester), and a grant to a predoctoral student, Amber Mueller, both for studies of our xenografts.

 

Friends of FSH Research

FHSfriends-logo_sWe currently hold a small grant from the Friends of FSH Research to use our xenografts to study the pathogenic mechanisms of FSHD.

 

Private Donations

We have been fortunate to receive generous funding from the Williams family and from the Kahlert Foundation to advance our studies of muscle and diseases of skeletal muscle. We welcome inquiries from individuals, families or organizations with interests in muscular dystrophy or myopathy. Donations can be facilitated by the University of Maryland Foundation, which provides a seamless and secure mechanism for tax-deductible donations to support our research program.